H.R. 5327House115th Congress (2017-2019)Passed House

Comprehensive Opioid Recovery Centers Act of 2018

Introduced March 19, 2018

AI-Generated Summary

Updated April 15, 2026 at 8:55 PM UTC

The Comprehensive Opioid Recovery Centers Act of 2018 creates a federal grant program to fund the establishment and operation of comprehensive opioid recovery centers across the United States. The program aims to provide a full range of treatment, recovery, and outreach services for people with opioid use disorder and related substance use disorders. Funding of $10 million per year is authorized for fiscal years 2019‑2023, and at least ten centers must be created.

Key Provisions

  • The Secretary of Health and Human Services awards competitive grants to eligible entities to create or run a recovery center, with grant terms of 3‑5 years and possible renewal based on performance data.
  • At least ten centers must be established nationwide, with priority given to locations in states or Indian country that have high per‑capita overdose death rates.
  • Each center must provide outreach (training, education), a full continuum of treatment services (medication‑assisted treatment, detox, counseling, residential care, recovery housing, job training, etc.), onsite pharmacy and toxicology, electronic health records, and family support services.
  • Grant recipients must submit annual data on program activities, health outcomes, and effectiveness, and the Secretary must report preliminary and final findings to Congress.
  • Appropriations of $10 million are authorized for each fiscal year from 2019 through 2023 to fund the program.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

16 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 13, 2018

View full timeline
HouseIntro Referral

Introduced in House

March 19, 2018

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

March 19, 2018

HouseIntro Referral

Sponsor introductory remarks on measure. (CR H3434)

April 18, 2018

HouseCommittee

Referred to the Subcommittee on Health.

April 25, 2018

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

April 25, 2018

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

April 25, 2018

HouseCommittee

Committee Consideration and Mark-up Session Held.

May 9, 2018

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

May 9, 2018

HouseFloor

Mr. Carter (GA) moved to suspend the rules and pass the bill, as amended.

June 12, 2018 • 4:34 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5055-5057)

June 12, 2018 • 4:35 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 5327.

June 12, 2018 • 4:35 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

June 12, 2018 • 4:44 PM

HouseFloor

Considered as unfinished business. (consideration: CR H5074-5075)

June 12, 2018 • 6:30 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 383 - 13 (Roll no. 258).(text: CR H5055-5056)

June 12, 2018 • 6:59 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 383 - 13 (Roll no. 258). (text: CR H5055-5056)

June 12, 2018 • 6:59 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

June 12, 2018 • 6:59 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

June 13, 2018

Floor Debate

11 members

What members said about H.R. 5327 on the floor

5 Republicans6 Democrats
Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Jun 12, 2018

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 5327, the Comprehensive Opioid Recovery Centers Act. Mr. Speaker, I rise in support of H.R. 5327, the…

Gene Green
Rep. Gene GreenD-TX-29 · Jun 12, 2018

Mr. Speaker, I thank my ranking member. Mr. Speaker, I rise in support of H.R. 5327, the Comprehensive Opioid Recovery Centers Act. The opioid epidemic is harming Americans in communities throughout…

Earl L. "Buddy" Carter
Rep. Earl L. "Buddy" CarterR-GA-1 · Jun 12, 2018

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5327) to amend title V of the Public Health Service Act to establish a grant program to create comprehensive opioid recovery centers,…

Ben Ray Luján
Rep. Ben Ray LujánD-NM-3 · Jun 12, 2018

Mr. Speaker, I thank Mr. Guthrie and Dr. Bucshon for working with myself and Mr. Gene Green of Texas on this bill. I rise today in support of the Comprehensive Opioid Recovery Centers Act. This bill…

Brett Guthrie
Rep. Brett GuthrieR-KY-2 · Jun 12, 2018

Mr. Speaker, I thank the chairman for yielding. Mr. Speaker, I rise today in support of my bill, the Comprehensive Opioid Recovery Centers Act, a bipartisan bill that will establish treatment centers…

Show 6 more
Greg Walden
Rep. Greg WaldenR-OR-2 · Jun 12, 2018

Mr. Speaker, I yield such time as he may consume to the gentleman from Kentucky (Mr. Guthrie), who is the vice chair of our Health Subcommittee and has been a leader on this opioid issue along with…

Peter J. Visclosky
Rep. Peter J. ViscloskyD-IN-1 · Jun 19, 2018

Mr. Speaker, on June 12, 2018, I was absent from the House and missed Roll Call votes 258, 259, and 260. Had I been present for Roll Call 258, on Motion to Suspend the Rules and Pass H.R. 5327, the…

Al Green
Rep. Al GreenD-TX-9 · Jun 13, 2018

Mr. Speaker, on Tuesday, June 12, 2018, I missed the following votes: H.R. 5327, Comprehensive Opioid Recovery Centers Act 2018. Had I been present, I would have voted YES on this bill. H.R. 5041,…

Dina Titus
Rep. Dina TitusD-NV-1 · Jun 14, 2018

Mr. Speaker, I was absent June 12, 2018 due to unforeseen circumstances. If I were present, I would have voted on the following: Roll no. 258--H.R. 5327--On motion to suspend the rules and pass the…

Gus M. Bilirakis
Rep. Gus M. BilirakisR-FL-12 · Jun 12, 2018

Mr. Speaker, on Tuesday, June 12, 2018, I was unavoidably detained and was unable to make votes that evening. Had I been present, I would have voted ``yea'' for rollcall 258, H.R. 5327--…

Robert Pittenger
Rep. Robert PittengerR-NC-9 · Jun 12, 2018

Mr. Speaker, on that I demand the yeas and nays.

Bill Text

3 versions available

Reading Mode
Latest
Referred in SenateIssued June 13, 2018

IIB

115th CONGRESS

2d Session

H. R. 5327

IN THE SENATE OF THE UNITED STATES

June 13, 2018

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To amend title V of the Public Health Service Act to establish a grant program to create comprehensive opioid recovery centers, and for other purposes.

1.

Short title

This Act may be cited as the Comprehensive Opioid Recovery Centers Act of 2018.

2.

Comprehensive opioid recovery centers

(a)

In general

Part D of title V of the Public Health Service Act is amended by adding at the end the following new section:

550.

Comprehensive opioid recovery centers

(a)

In general

The Secretary shall award grants on a competitive basis to eligible entities to establish or operate a comprehensive opioid recovery center (referred to in this section as a Center).

(b)

Grant period

(1)

In general

A grant awarded under subsection (a) shall be for a period not less than 3 years and not more than 5 years.

(2)

Renewal

A grant awarded under subsection (a) may be renewed, on a competitive basis, for additional periods of time, as determined by the Secretary. In determining whether to renew a grant under this paragraph, the Secretary shall consider the data submitted under subsection (h).

(c)

Minimum number of Centers

The Secretary shall allocate the amounts made available under subsection (i) in such amounts that not fewer than 10 Centers will be established across the United States.

(d)

Application

In order to be eligible for a grant under subsection (a), an entity shall submit an application to the Secretary at such time and in such manner as the Secretary may require. Such application shall include—

(1)

evidence that such entity carries out, or is capable of coordinating with other entities to carry out, the activities described in subsection (g); and

(2)

such other information as the Secretary may require.

(e)

Priority

In awarding grants under subsection (a), the Secretary shall give priority to eligible entities located in a State or Indian country (as defined in section 1151 of title 18, United States Code)—

(1)

with a high per capita drug overdose mortality rate, as determined by the Director of the Centers for Disease Control and Prevention; or

(2)

based on any other criteria or need, as determined by the Secretary.

(f)

Use of grant funds

An eligible entity awarded a grant under subsection (a) shall use the grant funds to establish or operate a Center to carry out the activities described in subsection (g).

(g)

Center activities and services

Each Center shall, at a minimum, carry out the activities described in this subsection. In the case of a Center that determines that a service described in paragraph (2) cannot reasonably be carried out by the Center, such Center shall contract with such other entities as may be necessary to ensure that patients have access to the full range of services described in such paragraph.

(1)

Community outreach

Each Center shall carry out the following outreach activities:

(A)

Train and supervise outreach staff to work with schools, workplaces, faith-based organizations, State and local health departments, law enforcement, and first responders to ensure that such institutions are aware of the services of the Center.

(B)

Disseminate and make available online evidence-based resources that educate professionals and the public on opioid use disorder and other substance use disorders.

(2)

Treatment and recovery services

Each Center shall provide the following treatment and recovery services:

(A)

Ensure that intake evaluations meet the clinical needs of patients.

(B)

Periodically conduct patient assessments to ensure continued and meaningful recovery, as defined by the Assistant Secretary for Mental Health and Substance Use.

(C)

Provide the full continuum of treatment services, including—

(i)

all drugs approved under section 505 of the Federal Food, Drug, and Cosmetic Act and all biological products licensed under section 351 of this Act, including methadone, to treat substance use disorders, including opioid use disorder and alcohol use disorder;

(ii)

withdrawal management, which shall include medically supervised detoxification that includes patient evaluation, stabilization, and readiness for and entry into treatment;

(iii)

counseling and case management, including counseling and recovery services for any possible co-occurring mental illness;

(iv)

residential rehabilitation;

(v)

recovery housing;

(vi)

community-based and peer recovery support services;

(vii)

job training and placement assistance to support reintegration into the workforce; and

(viii)

other best practices, as determined by the Secretary.

(D)

Administer an onsite pharmacy and provide toxicology services.

(E)

Establish and operate a secure and confidential electronic health information system.

(F)

Offer family support services such as child care, family counseling, and parenting interventions to help stabilize families impacted by substance use disorder.

(h)

Data reporting and program oversight

With respect to a grant awarded under subsection (a) to an eligible entity for a Center, not later than 90 days after the end of the first year of the grant period, and annually thereafter for the duration of the grant period (including the duration of any renewal period for such grant), the entity shall submit data, as appropriate, to the Secretary regarding—

(1)

the programs and activities funded by the grant;

(2)

health outcomes of individuals with a substance use disorder who received services from the Center;

(3)

the effectiveness of interventions designed, tested, and evaluated by the Center; and

(4)

any other information that the Secretary may require for the purpose of—

(A)

evaluating the effectiveness of the Center; and

(B)

ensuring that the Center is complying with all the requirements of the grant, including providing the full continuum of services described in subsection (g)(2)(C) and providing drugs and devices for overdose reversal under such subsection.

(i)

Authorization of appropriations

There is authorized to be appropriated $10,000,000 for each of fiscal years 2019 through 2023 for purposes of carrying out this section.

.

(b)

Reports to Congress

(1)

Preliminary report

Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a preliminary report that analyzes data submitted under section 550(h) of the Public Health Service Act, as added by subsection (a).

(2)

Final report

Not later than 1 year after submitting the preliminary report required under paragraph (1), the Secretary of Health and Human Services shall submit to Congress a final report that includes—

(A)

an evaluation of the effectiveness of comprehensive opioid recovery centers established or operated pursuant to section 550 of the Public Health Service Act, as added by subsection (a);

(B)

recommendations on whether the grant program established under such section 550 should be reauthorized and expanded; and

(C)

standards and best practices for the treatment of substance use disorders, as identified through such grant program.

Passed the House of Representatives June 12, 2018.

Karen L. Haas,

Clerk